A detailed history of Silicon Hills Wealth Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Silicon Hills Wealth Management, LLC holds 7,082 shares of NTLA stock, worth $86,542. This represents 0.16% of its overall portfolio holdings.

Number of Shares
7,082
Previous 7,082 -0.0%
Holding current value
$86,542
Previous $263,000 9.51%
% of portfolio
0.16%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$33.3 - $44.82 $13,752 - $18,510
-413 Reduced 5.51%
7,082 $263,000
Q4 2021

Feb 11, 2022

SELL
$100.76 - $138.36 $111,339 - $152,887
-1,105 Reduced 12.85%
7,495 $886,000
Q3 2021

Nov 15, 2021

SELL
$132.37 - $176.78 $2,647 - $3,535
-20 Reduced 0.23%
8,600 $1.15 Million
Q2 2021

Aug 16, 2021

BUY
$60.88 - $161.91 $6,514 - $17,324
107 Added 1.26%
8,620 $1.4 Million
Q4 2020

Feb 10, 2021

BUY
$18.83 - $63.53 $160,299 - $540,830
8,513 New
8,513 $463,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $929M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Silicon Hills Wealth Management, LLC Portfolio

Follow Silicon Hills Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silicon Hills Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silicon Hills Wealth Management, LLC with notifications on news.